Danny Shih
Impact in
-
- Drug Solubulity and Delivery Systems
-
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 6
- PARP inhibition in cancer therapy 3
- Colorectal Cancer Treatments and Studies 2
- HER2/EGFR in Cancer Research 2
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Karen L. Reckamp (2 shared papers)Derek Kennedy (1 shared paper)Egbert F. Smit (2 shared papers)Silvia Novello (2 shared papers)Wai Lee Wong (1 shared paper)Heather A. Wakelee (2 shared papers)James Chih‐Hsin Yang (2 shared papers)Paroma Chakravarty (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (1 paper)Journal of Clinical Oncology (1 paper)Journal of Immunological Methods (1 paper)ESMO Open (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
Danny Shih
7 papers receiving 48 citations
Peers
Comparison fields: 5 of 29
- Pharmaceutical Science 8
- Reproductive Medicine 6
- Oncology 18
- Pulmonary and Respiratory Medicine 17
- Molecular Biology 22
Countries citing papers authored by Danny Shih
This map shows the geographic impact of Danny Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Shih more than expected).
Fields of papers citing papers by Danny Shih
This network shows the impact of papers produced by Danny Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Shih. The network helps show where Danny Shih may publish in the future.
Co-authors
The 25 scholars most cited alongside Danny Shih, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 19 | |
| 2 | 2019 | 13 | |
| 3 | 2007 | 8 | |
| 4 | 2024 | 4 | |
| 5 | 2017 | 2 | |
| 6 | 2019 | 2 | |
| 7 | 2024 | 1 |
About Danny Shih
Danny Shih is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Reproductive Medicine, Immunology and Molecular Biology, having authored 7 papers that have together received 49 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Lung Cancer Treatments and Mutations (2 papers), HER2/EGFR in Cancer Research (2 papers), interferon and immune responses (1 paper), Cell death mechanisms and regulation (1 paper) and NF-κB Signaling Pathways (1 paper). The work is most often cited by research in Pharmaceutical Science (8 citations), Reproductive Medicine (6 citations), Oncology (18 citations), Pulmonary and Respiratory Medicine (17 citations) and Molecular Biology (22 citations). Danny Shih has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Karen L. Reckamp, Derek Kennedy, Egbert F. Smit, Silvia Novello, Wai Lee Wong, Heather A. Wakelee, James Chih‐Hsin Yang, Paroma Chakravarty, Anan Chuntharapai and Gregory L. Bennett. Their work appears in journals such as Journal of Pharmaceutical Sciences, Journal of Clinical Oncology, Journal of Immunological Methods, ESMO Open and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.